Cancer has become a major concern in healthcare globally, and over time, incidences and
prevalence of cancer are increasing. To counter this, a lot of anticancer drugs are approved …

Oncogenic BRAF mutations have been widely described in melanomas and promote tumour
progression and chemoresistance. We previously provided evidence that the HDAC inhibitor …

Colorectal cancer is the second leading cause of cancer-related mortality. Many current
therapies rely on chemotherapeutic agents with poor specificity for tumor cells. The clinical …

Gastric cancer has been considering one of the worst cancer types since it is diagnosed in
advanced stages, currently in the metastatic stage. Therefore, the challenge is to find out a …

Gastric cancer (GC) is among the most-diagnosed and deadly malignancies worldwide.
Deregulation in cellular bioenergetics is a hallmark of cancer. Based on the importance of …

We report here the synthesis of novel thymine biomimetic photo-adducts bearing an alkane
spacer between nucleobases and characterized by antimelanoma activity against two …

Bladder cancer (BC) is a primary source of malignancy‐associated death, and the mortality
rate is high due to its prevalence of metastasis. Corilagin (CLG), a bioactive constituent of …

Objectives To evaluate the anti‐inflammatory and antiproliferative effect of syringic acid
(SRA) on oral squamous cell carcinoma (OSCC) SCC131 cells via suppression of NF‐κB …

Gastric cancer (GC) is among the deadliest cancers worldwide despite available therapies,
highlighting the need for novel therapies and pharmacological agents. Metabolic …

Chemo-resistance has been reported as a relevant barrier for the efficiency of gastric cancer
treatment. Therefore, the development of effective and safe drugs for cancer chemotherapy …